Mepacrine hydrochloride, also known as quinacrine, is a synthetic compound originally developed as an antimalarial agent. Over the decades, its use has expanded to include treatments for a variety of other conditions such as
giardiasis,
systemic lupus erythematosus, and certain
dermatological disorders. Understanding the mechanism of mepacrine hydrochloride requires delving into its pharmacokinetics and biochemical interactions.
Upon oral administration, mepacrine hydrochloride is absorbed in the gastrointestinal tract and distributed throughout the body. It has a high affinity for tissues rich in nucleic acids, particularly the liver, spleen, and lungs. Its mechanism of action can be broadly categorized into several key roles:
1. **Interference with Nucleic Acid Synthesis**: Mepacrine hydrochloride intercalates into DNA strands, meaning it inserts itself between the base pairs of the DNA double helix. This intercalation disrupts the replication and transcription processes, which are critical for the proliferation of rapidly dividing cells such as malaria parasites and certain protozoans like Giardia. By inhibiting the synthesis of nucleic acids, mepacrine hydrochloride effectively curbs the growth and proliferation of these organisms.
2. **Inhibition of Phospholipase A2**: Phospholipase A2 is an enzyme involved in the inflammatory response and is responsible for the release of arachidonic acid from membrane phospholipids. By inhibiting this enzyme, mepacrine hydrochloride reduces the production of pro-inflammatory mediators such as prostaglandins and leukotrienes. This anti-inflammatory action is particularly beneficial in treating autoimmune conditions like systemic lupus erythematosus.
3. **Disruption of Cellular Membranes**: Mepacrine hydrochloride also has an affinity for cellular membranes, altering their permeability and fluidity. It can accumulate in lysosomes, leading to the disruption of these organelles. This mechanism contributes to its antiparasitic effects, as the integrity of cellular membranes in parasites is crucial for their survival.
4. **Inhibition of Autophagy**: Autophagy is a cellular process that involves the degradation and recycling of cellular components. Mepacrine hydrochloride has been shown to inhibit autophagy by interfering with the formation of autophagosomes. This inhibition can lead to the accumulation of defective proteins and organelles within cells, ultimately inducing cell death. This property is being explored for potential applications in
cancer therapy.
5. **Anti-Pruritic Effects**: In dermatology, mepacrine hydrochloride is used for its anti-pruritic (anti-itch) effects. Though the exact mechanism is not fully understood, it is believed to involve the stabilization of mast cells and the consequent reduction in the release of histamine and other itching mediators.
Mepacrine hydrochloride’s multifaceted mechanisms underscore its versatility in treating various diseases. However, its use is accompanied by potential side effects, including gastrointestinal disturbances,
skin discoloration, and, rarely, neuropsychiatric symptoms. Monitoring and appropriate dosing are essential to minimize these adverse effects.
In summary, mepacrine hydrochloride acts through a combination of nucleic acid intercalation, enzyme inhibition, cellular membrane disruption, autophagy inhibition, and anti-pruritic actions. These mechanisms collectively contribute to its efficacy in treating a range of conditions, making it a valuable, though complex, therapeutic agent.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


